You are viewing an incomplete version of our website. Please click to reload the website as full version.

WNK Lysine Deficient Protein Kinase 2 (WNK2) (AA 2118-2218) antibody

Details for Product No. ABIN393413, Supplier: Log in to see
Antigen
  • WNK2
  • ARABIDOPSIS THALIANA WITH NO K 2
  • ATWNK2
  • PROTEIN KINASE
  • ZIK3
  • with no lysine (K) kinase 2
  • NY-CO-43
  • P/OKcl.13
  • PRKWNK2
  • SDCCAG43
  • 1810073P09Rik
  • AW122246
  • ESTM15
  • X83337
  • mKIAA1760
  • RGD1307284
Epitope
AA 2118-2218
5
2
2
2
1
1
Reactivity
Human
16
11
2
Host
Mouse
20
5
Clonality (Clone)
Monoclonal ()
Conjugate
Un-conjugated
1
1
1
Application
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), ELISA, Western Blotting (WB)
21
16
3
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Available images

Immunogen WNK2 (NP_006639, 2118 a.a. ~ 2218 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 K
Clone 2E10
Isotype IgG1 kappa
Specificity WNK2 (NP_006639, 2118 a.a. ~ 2218 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Purification This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
Alternative Name WNK2 (WNK2 Antibody Abstract)
Background Synonyms: Serine protease inhibitor J6, 47 kDa heat shock protein, Collagen-binding protein, Colligin, Serpin H1,Hsp47, Cbp1, Serpinh1
Molecular Weight 242676 DA
Gene ID 12406
NCBI Accession NP_006639
Research Area Phospho-specific antibodies, Protein Modifications, Cell Structure
Application Notes ELISA ~~ 1ug/ml~3ng/ml Western blot ~~ 1:500~1000 Immunohistochemistry ~~ 1.5ug/ml
Comment

Background: The protein encoded by this gene is a cytoplasmic serine-threonine kinase that contains cysteine in place of the lysine found at the conserved ATP-binding location in subdomain II of protein kinases. Since this protein does have kinase activity, it is possible that another lysine in the kinase subdomain I can substitute for the missing conserved lysine.

Restrictions For Research Use only
Concentration 0.5 mg/ml
Buffer PBS with 0.09% (w/v) sodium azide.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C/-20 °C
Storage Comment Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Expiry Date 6 months
Supplier Images
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) image for anti-WNK Lysine Deficient Protein Kinase 2 (WNK2) (AA 2118-2218) antibody (ABIN393413) Immunoperoxidase of monoclonal antibody to WNK2 on formalin-fixed paraffin-embedded h...
Immunohistochemistry (IHC) image for anti-WNK Lysine Deficient Protein Kinase 2 (WNK2) (AA 2118-2218) antibody (ABIN393413) anti-WNK Lysine Deficient Protein Kinase 2 (WNK2) (AA 2118-2218) antibody (Image 2)
Background publications Rose, Behm, Drgon et al.: "Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score." in: Molecular medicine (Cambridge, Mass.), Vol. 16, Issue 7-8, pp. 247-53, 2010 (PubMed).

Yoshida, Kato, Yokoi et al.: "Association of genetic variants with hemorrhagic stroke in Japanese individuals." in: International journal of molecular medicine, Vol. 25, Issue 4, pp. 649-56, 2010 (PubMed).

Oguri, Kato, Yokoi et al.: "Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals." in: American journal of hypertension, Vol. 23, Issue 1, pp. 70-7, 2009 (PubMed).

Yoshida, Kato, Yokoi et al.: "Association of gene polymorphisms with chronic kidney disease in Japanese individuals." in: International journal of molecular medicine, Vol. 24, Issue 4, pp. 539-47, 2009 (PubMed).

Jun, Hong, Lal et al.: "Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific." in: Neuro-oncology, Vol. 11, Issue 4, pp. 414-22, 2009 (PubMed).